JP2677546B2 - Ｖｉｉｉ因子フラグメントのコンプレックスの凝固活性剤 - Google Patents

Ｖｉｉｉ因子フラグメントのコンプレックスの凝固活性剤

Info

Publication number
JP2677546B2
JP2677546B2 JP8203345A JP20334596A JP2677546B2 JP 2677546 B2 JP2677546 B2 JP 2677546B2 JP 8203345 A JP8203345 A JP 8203345A JP 20334596 A JP20334596 A JP 20334596A JP 2677546 B2 JP2677546 B2 JP 2677546B2
Authority
JP
Japan
Prior art keywords
fviii
units
incubation
viii
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP8203345A
Other languages
English (en)
Japanese (ja)
Other versions
JPH09117281A (ja
Inventor
オレ・ノルドフアング
ミレラ・エズバン・レスミユツセン
Original Assignee
ノボ・ノルデイスク・エー／エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノボ・ノルデイスク・エー／エス filed Critical ノボ・ノルデイスク・エー／エス
Publication of JPH09117281A publication Critical patent/JPH09117281A/ja
Application granted granted Critical
Publication of JP2677546B2 publication Critical patent/JP2677546B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP8203345A 1986-06-24 1996-08-01 Ｖｉｉｉ因子フラグメントのコンプレックスの凝固活性剤 Expired - Fee Related JP2677546B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK295786A DK295786A (da) 1986-06-24 1986-06-24 Fremgangsmaade til fremstilling af et koagulationsaktivt kompleks af faktor viii fragmenter
DK2957/86 1986-06-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP62504030A Division JP2593500B2 (ja) 1986-06-24 1987-06-24 ▲ｖｉｉｉ▼因子フラグメントの凝固活性複合物の製造方法

Publications (2)

Publication Number Publication Date
JPH09117281A JPH09117281A (ja) 1997-05-06
JP2677546B2 true JP2677546B2 (ja) 1997-11-17

Family

ID=8117562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8203345A Expired - Fee Related JP2677546B2 (ja) 1986-06-24 1996-08-01 Ｖｉｉｉ因子フラグメントのコンプレックスの凝固活性剤

Country Status (4)

Country Link
JP (1) JP2677546B2 (da)
AT (1) ATE100825T1 (da)
DK (2) DK295786A (da)
FI (1) FI100107B (da)

Also Published As

Publication number Publication date
FI880852A0 (fi) 1988-02-23
DK163833B (da) 1992-04-06
FI880852L (fi) 1988-02-23
DK295786D0 (da) 1986-06-24
FI100107B (fi) 1997-09-30
DK163833C (da) 1992-09-21
DK295786A (da) 1987-12-25
DK92188D0 (da) 1988-02-23
JPH09117281A (ja) 1997-05-06
DK92188A (da) 1988-02-23
ATE100825T1 (de) 1994-02-15

Similar Documents

Publication Publication Date Title
US5543502A (en) Process for producing a coagulation active complex of factor VIII fragments
Hajjar The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen.
Lundblad et al. The activation of antihemophilic factor (factor VIII) by activated Christmas factor (activated factor IX)
JP2593500B2 (ja) ▲ｖｉｉｉ▼因子フラグメントの凝固活性複合物の製造方法
US7160540B2 (en) Methods for detecting activity of clottings factors
WO2002003075A2 (en) Methods for detecting activity of clotting factors
Cooper et al. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
DEGUCHI et al. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex
Shuman et al. The perturbation of thrombin binding to human platelets by anions.
Egeberg On the natural blood coagulation inhibitor system investigations of inhibitor factors based on antithrombin deficient blood
CA2154080C (en) Novel anticoagulant cofactor activity
JPH09165397A (ja) 因子ＶＩＩおよび活性化因子ＶＩＩａの精製法
Mohammed et al. Multiple active forms of thrombin: binding to platelets and effects on platelet function.
EP0472205B1 (en) Assays using a soluble fibrin-like monomer
Bertina et al. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment
JP2677546B2 (ja) Ｖｉｉｉ因子フラグメントのコンプレックスの凝固活性剤
Weinstein et al. Species specificity of the fibrinolytic effects of activated protein C
Walker et al. The molecular mechanisms of heparin action: III. The anticoagulant properties of polyanetholesulfonate
Mimuro et al. Level of protein C determined by combined assays during disseminated intravascular coagulation and oral anticoagulation
US5529905A (en) Method of assaying plasma proteins with prothrombin fragments
CA2137342A1 (en) Test for quantitative thrombin time
Kandall et al. Determinants of Prothrombinase Activity and Modification of Prothrombin Conversion by Thrombin‐Treated Factor V
JP2593500C (da)
Seghatchian et al. Absorption of factor VIII by aluminium hydroxide
Bom et al. Immunoradiometric assays for human coagulation factor VII using polyclonal antibodies against the Ca (II)-dependent and Ca (II)-independent conformation

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees